NUVB Nuvation Bio Inc.
Nuvation Bio Inc. (NUVB) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 41% planned / 59% discretionary
Largest single sale: $2.2M.
Where they traded
Last open-market purchase: June 9, 2026 , by Mashal Robert .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sell 10b5-1 | 100,000 | $7.09 | $709.2K | None left | |
| Markel Stacy | CHIEF PEOPLE OFFICER | Sell 10b5-1 | 125,000 | $6.03 | $753.2K | 32,591 −79.3% of holding | |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | Sell 10b5-1 | 63,000 | $6.02 | $379.2K | 53,000 −54.3% of holding | |
| Sauvage Philippe | Chief Financial Officer | Sell 10b5-1 | 47,668 | $6.01 | $286.4K | 12,673 −79% of holding | |
| Mashal Robert | Director | Buy | 25,000 | $4.73 | $118.3K | 225,000 | |
| Liu Dongfang | CHIEF MEDICAL OFFICER | Sell 10b5-1 | 50,000 | $5.02 | $251.0K | 18,000 −73.5% of holding | |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | Sell 10b5-1 | 36,750 | $5.01 | $184.3K | 53,000 −40.9% of holding | |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | Sell 10b5-1 | 200,000 | $4.52 | $903.6K | 53,000 −79.1% of holding | |
| Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 150,000 | $7.82 | $1.2M | 18,000 −89.3% of holding | |
| Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 10,000 | $8.00 | $80.0K | 18,000 −35.7% of holding | |
| Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 10,000 | $7.50 | $75.0K | 18,000 −35.7% of holding | |
| Hattersley Gary 2 fills | CHIEF SCIENTIFIC OFFICER | Sell | 369,051 | $7.23 | $2.7M | None left | |
| Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 20,000 | $7.00 | $140.1K | 18,000 −52.6% of holding | |
| Hanley David C. | CHIEF TECHNICAL OPERATIONS | Sell | 200,000 | $7.14 | $1.4M | 24,000 −89.3% of holding | |
| Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 15,000 | $5.10 | $76.6K | 18,000 −45.5% of holding | |
| Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 15,000 | $4.76 | $71.5K | 15,000 −50% of holding | |
| Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sell 10b5-1 | 100,000 | $5.02 | $502.5K | None left |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.